USPTO US Appeals Court Reverses Patent Office Decision That Blocked Snipr Biome CRISPR IP The appeals court found that the US Patent Trial and Appeal Board had erred in subjecting Snipr's patents to an interference, which was eliminated under a recent patent law change. USPTO Rules in Favor of Broad Institute in CRISPR/Cas9 IP Dispute The Broad's CRISPR/Cas9 patents were found to have priority over similar IP from the University of California and others. Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable This week, the US PTAB found that some claims of a Personal Genomics patent for single-molecule detection didn't hold up, while others remain valid. US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents. Rakuten Medical Sues Illumina Over Trademark Dispute The cancer therapy developer has asked a US federal court to declare that its Illuminox platform does not infringe Illumina's trademarks. Apr 23, 2020 USPTO Board Denies Illumina Request to Review BGI Patent Aug 1, 2019 CRISPR Patent Fight Turns Ugly as UC Accuses Broad Researchers of Lying About Claims Jul 31, 2019 CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles Premium Jun 25, 2019 CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference Jun 14, 2019 USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium Jan 17, 2018 Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent Oct 28, 2016 CRISPR Patent Interference Likely Heads to Oral Arguments Over Preliminary Motions Premium Jun 1, 2016 Illumina Sues Qiagen for Patent Infringement Oct 9, 2015 USPTO Report to Congress Says No Immediate Action Necessary on Confirmatory Genetic Testing Nov 6, 2014 IP Update: Recent Patents Awarded to Alnylam Pharmaceuticals, Marina Biotech, and More Premium Oct 30, 2014 IP Update: Recent Patents Awarded to SomaGenics, Pioneer Hi-Bred, and More Premium Oct 29, 2014 USPTO Appeals Board Invalidates Claims on Illumina Patent Included in Qiagen-IBS Litigation Oct 16, 2014 IP Update: Recent Patents Awarded to Alnylam, Quark, Qiagen, and More Premium Sep 25, 2014 IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More Premium Aug 27, 2014 Legal Experts Assess Potential Impact of GeneDx's IPR Challenge of Myriad Patents Premium Aug 19, 2014 GeneDx Files IPR Petitions at USPTO against 11 Patents at Issue in Myriad Lawsuit Aug 14, 2014 IP Update: Recent Patents Awarded to Alnylam, Tekmira, Polyplus, and More Premium Aug 7, 2014 IP Update: Recent Patents Awarded to Alnylam, RXi, IBM, and More Premium Jul 31, 2014 IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More Premium Load More Breaking News SARS-CoV-2 Variants of Concerns Evolved to Modify Host Immune Response, Multiomics Study Shows People in the News at GA4GH, Mercy BioAnalytics, Deepcell, One Biosciences New Products Posted to GenomeWeb: Clinical Microbiomics, Integra Biosciences, DNAstack, Bruker Angolan Namib Desert Population Analysis Uncovers New Ancestry Group With Deep Divergence Cedars-Sinai Sets Up $25M Single Cell Precision Medicine Center The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.